For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Atyr Pharma Inc (NASDAQ: LIFE) was $1.60 for the day, up 1.91% from the previous closing price of $1.57. In other words, the price has increased by $1.91 from its previous closing price. On the day, 0.78 million shares were traded. LIFE stock price reached its highest trading level at $1.62 during the session, while it also had its lowest trading level at $1.5539.
Ratios:
Our analysis of LIFE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.27 and its Current Ratio is at 6.27. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.15.
On October 12, 2021, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $22.
On September 21, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $19.Piper Sandler initiated its Overweight rating on September 21, 2021, with a $19 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 06 ’24 when Broadfoot Jill Marie sold 1,590 shares for $1.69 per share. The transaction valued at 2,687 led to the insider holds 20,821 shares of the business.
Shukla Sanjay bought 12,000 shares of LIFE for $14,136 on Dec 12 ’23. The President and CEO now owns 106,173 shares after completing the transaction at $1.18 per share. On Dec 11 ’23, another insider, Shukla Sanjay, who serves as the President and CEO of the company, bought 3,000 shares for $1.17 each. As a result, the insider paid 3,510 and bolstered with 94,173 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIFE now has a Market Capitalization of 108705280 and an Enterprise Value of 25141038. For the stock, the TTM Price-to-Sale (P/S) ratio is 309.71 while its Price-to-Book (P/B) ratio in mrq is 1.12. Its current Enterprise Value per Revenue stands at 71.221 whereas that against EBITDA is -0.463.
Stock Price History:
The Beta on a monthly basis for LIFE is 1.26, which has changed by -0.19191921 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, LIFE has reached a high of $2.70, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is -11.27%, while the 200-Day Moving Average is calculated to be -1.14%.
Shares Statistics:
LIFE traded an average of 554.88K shares per day over the past three months and 348120 shares per day over the past ten days. A total of 67.75M shares are outstanding, with a floating share count of 65.66M. Insiders hold about 3.09% of the company’s shares, while institutions hold 60.59% stake in the company. Shares short for LIFE as of 1713139200 were 383052 with a Short Ratio of 0.69, compared to 1710460800 on 289272. Therefore, it implies a Short% of Shares Outstanding of 383052 and a Short% of Float of 0.8.
Earnings Estimates
The stock of Atyr Pharma Inc (LIFE) is currently in the spotlight, with 5.0 analysts actively rating and assessing its market standing.On average, analysts expect EPS of -$0.24 for the current quarter, with a high estimate of -$0.18 and a low estimate of -$0.29, while EPS last year was -$0.29. The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.19 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$0.75 and -$1.19 for the fiscal current year, implying an average EPS of -$0.94. EPS for the following year is -$0.95, with 4.0 analysts recommending between -$0.64 and -$1.11.
